BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17611965)

  • 21. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
    Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S
    Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate-induced accelerated nodulosis in a patient with rheumatoid arthritis and scleroderma.
    Motegi S; Ishikawa O
    Acta Derm Venereol; 2014 May; 94(3):357-8. PubMed ID: 24158350
    [No Abstract]   [Full Text] [Related]  

  • 24. [Discussion on the necessity of treatment of rheumatoid arthritis with integrative Chinese and Western medicine].
    Wu QF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jul; 27(7):584-5. PubMed ID: 17717909
    [No Abstract]   [Full Text] [Related]  

  • 25. Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.
    Onishi S; Yoshio T; Nagashima T; Minota S
    Mod Rheumatol; 2010 Oct; 20(5):528-30. PubMed ID: 20458607
    [No Abstract]   [Full Text] [Related]  

  • 26. Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis.
    Cohen JD; Zaltni S; Kaiser MJ; Bozonnat MC; Jorgensen C; Daurès JP; Sany J
    Ann Rheum Dis; 2004 Feb; 63(2):209-10. PubMed ID: 14722213
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
    J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
    Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
    Sakaida H; Komase Y; Takemura T
    Mod Rheumatol; 2010 Dec; 20(6):611-6. PubMed ID: 20585825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiographic remodeling of the shoulder joint in a patient with rheumatoid arthritis after 4 years of treatment with etanercept.
    Ozaki T; Hashizume K; Nakahara R; Nishida K
    Mod Rheumatol; 2012 Aug; 22(4):635-7. PubMed ID: 22318335
    [No Abstract]   [Full Text] [Related]  

  • 31. Two is better than one? Combination therapy in rheumatoid arthritis.
    Choy EH
    Rheumatology (Oxford); 2004 Oct; 43(10):1205-7. PubMed ID: 15226519
    [No Abstract]   [Full Text] [Related]  

  • 32. Response times follow lognormal or gamma distribution in arthritis patients.
    Abrahamyan L; Beyene J; Feng J; Chon Y; Willan AR; Schmeling H; Horneff G; Keystone EC; Feldman BM
    J Clin Epidemiol; 2010 Dec; 63(12):1363-9. PubMed ID: 20430577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.
    Bathon JM; McMahon DJ
    N Engl J Med; 2013 Jul; 369(4):384-5. PubMed ID: 23755970
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
    Ferraccioli G
    Reumatismo; 2005; 57(4 Suppl):17-21. PubMed ID: 16385351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid arthritis: still a chronic disease.
    Miossec P
    Lancet; 2013 Mar; 381(9870):884-6. PubMed ID: 23332235
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?
    O'Dell JR
    N Engl J Med; 1999 Jan; 340(4):310-2. PubMed ID: 9920958
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N; Max R; Schiller M; Briem S; Lorenz HM
    Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
    [No Abstract]   [Full Text] [Related]  

  • 40. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?
    Tiliakos AN; Tiliakos NA
    J Rheumatol; 2003 Dec; 30(12):2727. PubMed ID: 14719226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.